Alvotech to report first six months and second quarter 2022 financial results on august 31, 2022 and host business update conference call at 8:00 am et on september 1, 2022

Reykjavik, iceland, aug. 15, 2022 (globe newswire) -- alvotech (nasdaq: alvo), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results for the first six months and second quarter of 2022, after u.s. markets close on wednesday, august 31, 2022.
ALVO Ratings Summary
ALVO Quant Ranking